Document:

Exhibit
10.9(i)

 

FIFTH
EXTENSION AGREEMENT

 

This
FIFTH EXTENSION AGREEMENT (this “Agreement”) dated as of July 19, 2022, and effective as of July 16, 2022 by and between
ADAMAS ONE CORP., a Nevada corporation (“Company”) and Target Capital 3 LLC, an Arizona limited liability company
(“Investor”). Each of the Company and the Investor are a “Party” to this Agreement, and one or
more of them, as the context shall require, are the “Parties” hereto.

 

RECITALS:

 

WHEREAS,
the Company has executed and delivered to Investor, inter alia, those certain Senior Secured Convertible Note Purchase Agreements
dated as of June 1, 2021 and June 3, 2021, together with all Exhibits and Schedules thereto (the “Note Purchase Agreements”),
including but not limited to the Senior Secured Convertible Promissory Notes in the principal amount of $2,100,000 dated June 1, 2021
and June 3, 2021, which have, as of July 19, 2022, an aggregate outstanding principal balance of $2,100,000 (“Note”);

 

WHEREAS,
the Company and the Investor executed an Extension Agreement dated March 30, 2022 extending the term of the Note to April 15, 2022 (“First
Extension Agreement”);

 

WHEREAS,
the Company and the Investor executed an Extension Agreement dated April 25, 2022 extending the term of the Note to May 15, 2022 (“Second
Extension Agreement”);

 

WHEREAS,
the Company and the Investor executed an Extension Agreement dated May 16, 2022 extending the term of the Note to June 15, 2022 (“Third
Extension Agreement”);

 

WHEREAS,
the Company and the Investor executed an Extension Agreement dated June 17, 2022 extending the term of the Note to July 16, 2022 (“Fourth
Extension Agreement”);

 

WHEREAS,
the Company has requested that Investor extend the term of the Note to August 15, 2022 in exchange for an additional 50,000 Incentive
Shares (as defined in the Note Purchase Agreements) to be issued and delivered by the Company to the Investor, and Investor is willing
to do so on the terms and conditions set forth below;

 

NOW,
THEREFORE, for and in consideration of the mutual covenants contained herein and for other valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto agree as follows:

 

1. Defined
Terms. Capitalized terms used but not defined in this Agreement shall have the meaning given to such capitalized terms in the
Note Purchase Agreements.

 

2. Extension
of Maturity Date. The maturity date of the Note is hereby extended to 5:00 p.m. New York City, New York Time on August 15, 2022
(the “Maturity Date”). The liens, interests, assignments, and other rights evidenced by the Note Purchase Agreements
and including the first perfected security interest in the Collateral as set forth in the Security Agreements are hereby renewed and
extended to secure payment of the Note as extended hereby. The Company shall evidence its agreement to such extension and its agreement
to timely pay the Note and all other Obligations thereunder on the Maturity Date by its signature hereon and on the Allonge to the Promissory
Note which will amend and be attached to the Promissory Note, be incorporated therein and made a part thereof. While the extension of
the Maturity Date of the Fourth Extension Agreement has expired, the parties agree that all of the terms and conditions of the Fourth
Extension Agreement, other than the extended Maturity Date, shall continue to survive to the extent such terms and conditions do not
conflict with this Fifth Extension Agreement. 

    
	Fifth Extension Agreement	1

     

    

3. Extension
Fee. As a condition to the extension of the Maturity Date, the Company shall issue to the Investor, upon the signing by the
Company of this Agreement, 50,000 shares of the Company’s restricted common stock, $0.001 par value per share
(“Common Stock”), as additional Incentive Shares (“Additional Incentive Shares”) as a
consideration for the extension of the maturity date of the Note. All such Additional Incentive Shares shall be issued and delivered
by the Company to the Investor within five (5) business days after the date of the execution of this Agreement by the Company. All
of such shares will be duly authorized, validly issued, fully paid and non-assessable and without any lien of the Company. Should
the Company fail to issue the shares of Common Stock within such five (5) business days, the Company hereby agrees to pay to the
Investor, as liquidated damages and not as a penalty, the cash sum of $1,000.00 per day for every day until all of such shares have
been delivered to the Investor. For all relevant purposes, the number of shares to be issued and delivered to the Investor, shall be
appropriately adjusted to take into account any stock split, stock dividend, reverse stock split, recapitalization, issuance of
additional share (regardless of the purpose and regardless of the price) or similar change in the Company’s Common Stock,
which may occur between the date of the execution of this Agreement and the closing date of the Company’s initial public
offering (“IPO”). For clarity, in the event the Company undertakes a reverse stock split prior to the IPO, the
Company agrees to issue additional shares so that the Investor will have 50,000 restricted shares of Common Stock on the date
immediately post-reverse stock split and on the date of the closing of the IPO. However, notwithstanding the foregoing, the Investor
shall not receive shares of Common Stock that would cause it to be the beneficial owner of more than 9.99% of the Company’s
issued and outstanding shares of Common Stock on the date immediately post-reverse stock split. Any such shares that exceed the
9.99% shall be held in trust for the Investor by the Company and shall thereafter be issued to the Investor, immediately upon its
request, at any time or from time to time, when such shares would not cause the Investor to be the owner of more than 9.99% of the
Company’s issued and outstanding shares of Common Stock. For avoidance of doubt, the total number of Additional Incentive
Shares to be issued to the Investor from the First Extension Agreement, the Second Extension Agreement, Third Extension Agreement,
Fourth Extension Agreement and this Fifth Extension Agreement is 200,000.

 

4. Registration
of Shares. The Company hereby agrees that it will register all Additional Incentive Shares issuable hereunder in the registration
statement that it has filed confidentially with the U.S. Securities and Exchange Commission and that it will file publicly hereafter
for the Company’s IPO.

 

5. True-Ups.
All of the Additional Incentive Shares to be issued to the Investor hereunder shall be considered to be “Investor Registrable
Securities” under the Registration Rights Agreement dated May 24, 2021 and June 3, 2021 (“Registration Rights
Agreement”) by and between the Investor and the Company and shall have all of the rights that the other such Investor
Registrable Securities have in accordance therewith. In addition, for good and valuable consideration, the receipt of which is
hereby acknowledged by the Company, if the closing price of one share of the Common Stock issued under this Extension Agreement on
its first day of trading on a national securities exchange immediately following the date upon which the Lock-Up expires, is below
the per share offering price in the Company’s final prospectus, the Company agrees to issue to the Investor, without further
payment by the Investor a number of shares of Common Stock (“Additional Shares”) equal to the following
formula:

 

	●	Step
                                            1: X multiplied by CP = Y
	 	 
	●	Step
                                            2: X multiplied by OP = W

    
	Fifth Extension Agreement	2

     

    

	●	Step
                                            3: If W is equal to Y, there shall be no adjustment;
	 	 
	●	Step
                                            4: If W is greater than Y, then W minus Y = Z
	 	 
	●	Step
                                            5: Z divided by CP = A.
	 	 
	Where:
“CP” is the actual closing price of the Common Stock on the first trading day after the Lock-Up expires;
	 
	“OP”
is the offering price of the Common Stock in the IPO;
	 
	“W”
is the product of the number of Incentive Shares, Conversion Shares (if any) and Warrant Shares (if any) owned by the Investor on the
date that the Lock-Up expires multiplied by the offering price of the Common Stock in the IPO;
	 
	“X”
is the number of Incentive Shares, Conversion Shares (if any) and Warrant Shares (if any) owned by the Investor on the date that the
Lock-Up expires;
	 
	“Y”
is the product of the number of Incentive Shares, Conversion Shares (if any) and Warrant Shares (if any) owned by the Investor on the
date that the Lock-Up expires multiplied by the actual closing price of the Common Stock on the first trading day after the Lock-Up expires;
	 
	“Z”
is the result of the difference between (i) product of the number of Incentive Shares, Conversion Shares (if any) and Warrant Shares
(if any) owned by the Investor on the date that the Lock- Up expires multiplied by the offering price of the Common Stock in the IPO
and (ii) the product of the number of Incentive Shares, Conversion Shares (if any) and Warrant Shares (if any) owned by the Investor
on the date that the Lock-Up expires multiplied by the actual closing price of the Common Stock on the first trading day after the Lock-Up
expires;
	 
	“A”
represents the number of shares to be issued to the Investor by the Company if the closing price of the Common Stock on the first trading
day after the Lock-Up expires is less than the offering price.
	 
	So,
for example, if X = 100,000 shares; CP = $4.25; and OP = $5.00, then:
	 	 
	●	Step
                                            1: 100,000 multiplied by $4.25 = $425,000;
	 	 
	●	Step
                                            2: 100,000 multiplied by $5.00 = $500,000;
	 	 
	●	Step
                                            3: $500,000 minus $425,000 = $75,000;

    
	Fifth Extension Agreement	3

     

    

	●	Step
                                            4: $75,000 divided by $4.25 = 17,647.06;
	 	 
	Proof:
100,000 + 17,647.06 = 117,647.06 total shares multiplied by $4.25 = $500,000.

 

The
Company shall be obligated to deliver the non-registered Additional Shares within ten (10) business days after the expiration date of
the Lock-Up, which Shares shall be duly authorized, validly issued and non-assessable and shall contain a legend stating that they were
issued pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended, the transfer of such shares
being restricted thereunder.

 

5. Representations
and Warranties. The Company hereby represents and warrants that (a) the Company is the sole legal and beneficial owner of the
Collateral; (b) ADAMAS ONE CORP. is duly organized and legally existing under the laws of the State of Nevada ; (c) the execution and
delivery of, and performance under this Agreement are within the Company’s power and authority without the joinder or consent of
any other party and have been duly authorized by all requisite action and are not in contravention of law or the powers of the Company’s
respective organization documents; (d) this Agreement constitutes the legal, valid and binding obligations of the Company enforceable
in accordance with its terms; (e) the execution and delivery of this Agreement by the Company do not contravene, result in a breach of
or constitute a default under any deed of trust, loan agreement, indenture or other contract, agreement or undertaking to which the Company
is a party or by which the Company or any of its properties may be bound (nor would such execution and delivery constitute such a default
with the passage of time or the giving of notice or both) and do not violate or contravene any law, order, decree, rule or regulation
to which the Company is subject; and (f) to the best of the Company’s knowledge there exists no uncured default under any of the Note
Purchase Agreements or Note. The Company agrees to indemnify and hold Investor harmless against any loss, claim, damage, liability or
expense (including without limitation reasonable attorneys’ fees) incurred as a result of any representation or warranty made by it herein
proving to be untrue in any respect.

 

6. Further
Assurances. The Company, upon request from Investor, agrees to execute such other and further documents as may be reasonably
necessary or appropriate to consummate the transactions contemplated herein or to perfect the liens and security interests intended to
secure the payment of the loan evidenced by the Note.

 

7.  Default; Remedies. If the Company shall fail to keep
or perform any of the covenants or agreements contained herein (subject to the applicable notice and cure periods provided in the Note
Purchase Agreements) or if any statement, representation or warranty contained herein is false, misleading or erroneous in any material
respect, the Company shall be deemed to be in default under the Note Purchase Agreements and the Note and Investor shall be entitled
at its option to exercise any and all of the rights and remedies granted pursuant to the Note Purchase Agreements or to which Investor
may otherwise be entitled, whether at law or in equity.

 

8.  Ratification
of Note Documents. Except as provided herein, the terms and provisions of the Note Purchase Agreements and all other documents
related thereto, including but not limited to the Note, shall remain unchanged and shall remain in full force and effect. Any modification
herein of the Note Purchase Agreements or the Note shall in no way adversely affect the security interest on the Collateral for the payment
of the Note. The Note Purchase Agreements and the Note as modified and amended hereby are hereby ratified and confirmed in all respects.
All liens, security interests, mortgages and assignments granted or created by or existing under the Note Purchase Agreements remain
unchanged and continue, unabated, in full force and effect, to secure the Company’s obligation to repay the Note. 

    
	Fifth Extension Agreement	4

     

    

9.  Liens
Valid; No Offsets or Defenses. The Company hereby acknowledges that the liens, security interests and assignments created and
evidenced by the Note Purchase Agreements, the Notes and the Security Agreement are valid and subsisting and further acknowledges and
agrees that there are no offsets, claims or defenses to any of the documents related to the Note and Note Purchase Agreements.

 

10. Entire
Agreement. Except as otherwise stated herein, this Agreement supersedes and merges all prior and contemporaneous promises, representations
and agreements regarding this Fifth Extension Agreement. No modification of this Agreement or of the Note Purchase Agreements or the
Note or any other document related thereto, or any waiver of rights under any of the foregoing, shall be effective unless made by supplemental
agreement, in writing, executed by Investor and the Company. Investor and the Company further agree that this Agreement may not in any
way be explained or supplemented by a prior, existing or future course of dealings between the parties or by any prior, existing, or
future performance between the parties pursuant to this Agreement or otherwise.

 

11.  Notices.
Any notice or communication required or permitted hereunder or under the Note Purchase Agreements shall be given in writing and sent
in the manner required under the Note Purchase Agreements.

 

12.  Costs
and Expenses. Contemporaneously with the execution and delivery hereof, the Company shall pay, or cause to be paid, all costs
and expenses incident to the preparation hereof and the consummation of the transactions specified herein, including without limitation
recording fees and fees and expenses of legal counsel to Investor.

 

13.  Release
of Investor. The Company hereby releases, remises, acquits and forever discharges Investor, together with its manager, members,
participants, employees, agents, representatives, consultants, attorneys, fiduciaries, servants, officers, directors, partners, predecessors,
successors and assigns, (all of the foregoing hereinafter called the “Released Parties”), from any and all actions
and causes of action, judgments, executions, suits, debts, claims, demands, liabilities, obligations, damages and expenses of any and
every character, known or unknown, direct and/or indirect, at law or in equity, of whatsoever kind or nature, whether heretofore or hereafter
accruing, for or because of any matter or things done, omitted or suffered to be done by any of the Released Parties prior to and including
the date hereof, and in any way directly or indirectly arising out of or in any way connected to this Agreement, the First Extension
Agreement, the Second Extension Agreement, the Third Extension Agreement, the Fourth Extension Agreement or of the Note Purchase Agreements
including the Note, or any of the transactions associated therewith, including specifically but not limited to claims of usury.

 

14.  Counterparts.
This Agreement may be executed in any number of counterparts with the same effect as if all Parties hereto had signed the same document.
All such counterparts shall be construed together and shall constitute one instrument, but in making proof hereof it shall only be necessary
to produce one such counterpart. Fax or electronic copies of a document shall be deemed an original for all purposes.

 

15.  Severability.
If any covenant, condition, or provision herein contained is held to be invalid by final judgment of any court of competent jurisdiction,
the invalidity of such covenant, condition, or provision shall not in any way affect any other covenant, condition or provision herein
contained.

 

16.  Time
of the Essence. It is expressly agreed by the Parties hereto that time is of the essence with respect to this Agreement.

 

17.  Representation
by Counsel. The Parties acknowledge and confirm that each of their respective attorneys have participated jointly in the review
and revision of this Agreement and that it has not been  written
solely by counsel for one Party. The Parties hereto therefore stipulate and agree that the rule of construction to the effect that any
ambiguities are to or may be resolved against the drafting Party shall not be employed in the interpretation of this Agreement to favor
either Party against the other.

    
	Fifth Extension Agreement	5

     

    

18. Governing
Law. This Agreement and the rights and duties of the parties hereunder shall be governed for all purposes by the law of the State
of Arizona and the law of the United States applicable to transactions within said State, without giving effect to principles of conflicts
of law.

 

19.  Successors
and Assigns. The terms and provisions hereof shall be binding upon and inure to the benefit of the Parties hereto and their respective
successors. This Agreement is not assignable by the Company.

 

20.  Breach.
Any breach of this Agreement shall be an Event of Default under the Note Purchase Agreements and the Note and the Investor shall have
all rights under the Note Purchase Agreements and the Note in such event.

 

[THE
REMAINDER OF THIS PAGE LEFT BLANK INTENTIONALLY.]

 

[SIGNATURES
APPEAR ON THE NEXT PAGE.]

    
	Fifth Extension Agreement	6

     

    

IN
WITNESS WHEREOF, this Agreement is executed on and is effective as of March 30, 2022.

 

	ADAMAS
    ONE CORP.,
	as
    the Company
	 	 
	By:
    (Sign Here)  	/s/
    John Grdina
	Name:	John
    Grdina
	Title:	Chief
    Executive Officer
	 
	TARGET
    CAPITAL3 LLC,
	As
    the Investor
	 	 
	By:
    (Sign Here)  	/s/
    Dmitriy Shapiro
	Name:	Dmitriy
    Shapiro
	Title:	Managing
    Partner

    
	Fifth Extension Agreement	7Exhibit
10.9(j)

 

ADAMAS
ONE CORP.

411
University Ridge, Suite 110

Greenville,
South Carolina 29601

 

CONFIDENTIAL

 

March
30, 2022

 

Target
Capital 3 LLC

_________________

_________________

 

Re:
Issuance of Additional Shares

 

Dear
Mr. Shapiro:

 

This
letter (this “Amendment”) amends the side letter agreements executed on May 24, 2021 and June 3, 2021 (“Side
Letters”) between ADAMAS ONE CORP., a Nevada corporation (the “Company”), and Target Capital 3 LLC, an Arizona
limited liability company (the “Investor”), executed in connection with that certain Senior Secured Convertible Note
Purchase Agreements by and between the Company and the Investor dated May 24, 2021 and June 3, 2021 (the “Note Purchase Agreements”).

 

The
Investor has agreed to extend the maturity date of the Company’s eight percent (8%) interest bearing senior secured convertible
promissory note to April 15, 2022 by the Extension Agreement by and between the parties dated as of March 30, 2022 (“Extension
Agreement”).

 

In
consideration of such extension, the Company hereby agrees to issue to: (i) the Investor 50,000 shares of the Company’s restricted
common stock, $0.001 par value per share (“Common Stock”), pursuant to the Extension Agreement; and (ii) Alchemy Advisory,
LLC, a Limited Liability Company organized under the laws of Puerto Rico (“Alchemy”), 50,000 shares of the Company’s
restricted Common Stock (“Alchemy Shares”) pursuant to the amendment to the Consulting Agreement dated March 30, 2022
(“Consulting Agreement Amendment”).

 

The
Company hereby agrees that it will promptly register all shares: (i) issued to the Investor under the Extension Agreement; (ii) all Alchemy
Shares to be issued pursuant to the Consulting Agreement Amendment; (iii) as well as all Incentive Shares, Conversion Shares, all Warrants
and all Warrant Shares issuable to the Investor under the Note Purchase Agreements; and (iv) all Incentive Shares, Conversion Shares,
Warrants and Warrant Shares of Company Common Stock previously issued to Alchemy, in the registration statement that it has filed confidentially
with the U.S. Securities and Exchange Commission (“SEC”) and that it will file publicly hereafter for the Company’s
initial public offering (“IPO”). Notwithstanding the above, all of such shares in (i) through (iv), inclusive, shall
be considered to be “Investor Registrable Securities” under the Registration Rights Agreement dated May 24, 2021 and June
3, 2021 (“Registration Rights Agreement”) by and between the Investor and the Company “) and shall have all
of the rights that the other such Investor Registrable Securities have in accordance therewith. That Registration Rights Agreement contains
certain prohibitions on the sale of the previously issued Conversion Shares, Incentive Shares and Warrant Shares following the Company’s
IPO (the “Lock-Up”) which, would also apply to the shares being issued pursuant to the Extension Agreement and the
amendment to the Consulting Agreement. The Company acknowledges and agrees that all such shares subject to the Lock-Up continue to be
subject to the “true up” provisions in the Consulting Agreement dated June 3, 2021.

     

     

    

Target
Capital 3

March
30, 2022

Page
2

 

For
good and valuable consideration, the receipt of which is hereby acknowledged by the Company, the Company agrees that if the closing
price of one share of the Common Stock, on its first day of trading on a national securities exchange immediately following the date
upon which the Lock-Up expires, is below the per share initial public offering price in the Company’s final prospectus as
filed with the SEC (“Initial Price”), the Company agrees to issue to the Investor, without further payment by the
Investor, a number of shares of Common Stock as set forth in the Extension Agreement in Section 5 and the Consulting Agreement, as
amended, in Section 5. Further, the Company agrees that it will guarantee the Investor’s and Alchemy’s expected return
value of all of the shares issued to the Investor and to Alchemy pursuant to the Note Purchase Agreements, the Extension Agreement
and the Consulting Agreement Amendment, which shall be repeated until the Investor and Alchemy achieve their total expected return,
as follows:

 

(a)       With
respect to all of the shares of Common Stock granted to Alchemy pursuant to the Consulting Agreement as amended, if the 120,000 (or greater
number of) shares are sold by Alchemy in the market or in private transactions generate a return to Alchemy less than the product of:
(x) 120,000 (or greater number of) multiplied by (y) the Initial Price of the Common Stock (such product the “Alchemy
Guaranteed Return”), then the Company shall, upon written demand of Alchemy, issue to Alchemy such number of additional shares
of Common Stock until the Investor is able to achieve the Alchemy Guaranteed Return by the sale of such shares, whether in the market
or in private transactions.

 

(b)       With
respect to the 50,000 shares of Common Stock granted to the Investor pursuant to the Extension Agreement, if such shares are sold by
the Investor in the market or in private transactions generate a return to Target less than the product of (x) 50,000 multiplied by
(y) the Initial Price of the Common Stock (such product the “Target Guaranteed Extension Return”), then the Company
shall, upon written demand of Target, issue to Target such number of additional shares of Common Stock until Target is able to
achieve the Target Guaranteed Extension Return by the sale of such shares, whether in the market or in private
transactions.

 

(c)       With
respect to the Conversion Shares of Common Stock granted to the Investor pursuant to the Note Purchase Agreements, if such shares are
sold by the Investor in the market or in private transactions generate a return to the Investor less than the product of (x) such number
of shares of Common Stock subject to the Note Purchase Agreements, including all the Conversion Shares, multiplied by the Initial Price
of the Common Stock (such product the “Note Purchase Guaranteed Return”), then the Company shall, upon written demand
of the Investor, issue to the Investor such number of additional shares of Common Stock until the Investor is able to achieve the Note
Purchase Guaranteed Return by the sale of such shares, whether in the market or in public transactions.

 

All
such additional shares issued pursuant to sub-paragraphs (a), (b) and (c) above (“Guaranteed Shares”) shall be issued
and delivered by the Company to the Investor and/or Alchemy within five (5) business days after the date the Company receives a demand
therefor from the Investor and/or Alchemy. All of such shares will be duly authorized, validly issued, fully paid and non-assessable
and without any lien of the Company and shall be issued as “restricted” shares subject to Rule 144 under the Securities Act
of 1933, as amended. Should the Company fail to issue the shares of Common Stock within such five (5) business days, the Company hereby
agrees to pay to the Investor, as liquidated damages and not as a penalty, the cash sum of $1,000.00 per day for every day until all
of such shares have been delivered to the Investor.

     

     

    

Target
Capital 3

March
30, 2022

Page
3

 

At
any time: (i) on or after the expiration Lock-Up, and (ii) upon the issuance of the Guaranteed Shares, the Investor and/or Alchemy
may request in writing that the Company file a registration statement with respect to all or part of such Guaranteed Shares under
the Securities Act of 1933, as amended, on Form S-1 or any similar long-form registration or on Form S-3 or any similar short- form
registration if available (such requested registration, a “Demand Registration”). Such request for a Demand
Registration must specify the approximate number or dollar value of Guaranteed Shares requested to be registered by the Investor
and/or Alchemy and (if known) the intended method of distribution. The Investor and/or Alchemy will be entitled to select the
placement agent or underwriter for the Demand Registration and the Company will pay all expenses of such registration. Sections 3
(Registration Procedures), 5 (Indemnification and Contribution) and 8 (General Provisions) of that Registration Rights shall apply
to the Demand Registration as the context may require. The Company may postpone, for up to 90 days from the date of the request (the
“Suspension Period”), the filing or the effectiveness of a registration statement for the Demand Registration by
providing written notice to the Investor and/or Alchemy if the Company determines that the offer or sale of the Guaranteed Shares
would reasonably be expected to have a material adverse effect on any proposal or plan by the Company to engage in any material
acquisition of assets or stock (other than in the ordinary course of business) or any material merger, consolidation, tender offer,
recapitalization, reorganization, financing or other transaction involving the Company and upon advice of counsel, the sale of the
Guaranteed Shares pursuant to the registration statement would require disclosure of material non-public information not otherwise
required to be disclosed under applicable law, and (x) the Company has a bona fide business purpose for preserving the
confidentiality of such transaction, (y) disclosure would have a material adverse effect on the Company or the Company’s
ability to consummate such transaction, or (z) such transaction renders the Company unable to comply with the requirements of the
SEC, in each case under circumstances that would make it impractical or inadvisable to cause the registration statement (or such
filings) to become effective or to promptly amend or supplement the registration statement on a post-effective basis, as applicable.
The Company may delay or suspend the effectiveness of the Demand Registration pursuant to this paragraph only once in any twelve
(12)-month period. In addition, the Company need not comply with a request for the Demand Registration if the Investor and/or
Alchemy can include the Guaranteed Shares in a piggyback registration statement that the Company intends to file within thirty (30)
days after receipt of the request for a Demand Registration, provided however, if the piggyback registration statement is not filed
within forty five (45) days after receipt of the request for a Demand Registration, the Company shall proceed with the Demand
Registration.

 

The
Company hereby represents and warrants to the Investor that the execution and delivery of, and performance under this Amendment are within
the Company’s power and authority without the joinder or consent of any other party and has been duly authorized by all requisite
corporate action and are not in contravention of law or the powers of the Company’s organization documents and that this Amendment
constitutes the legal, valid and binding obligations of the Company enforceable in accordance with its terms. The Company has attached,
as Exhibit A hereto, a certified copy of the resolutions of the Company’s Board of Directors approving the above issuance
and delivery of the Common Stock to the Investor and to Alchemy.

 

The
Company, upon request from the Investor, agrees to execute such other and further documents as may be reasonably necessary or appropriate
to consummate the transactions contemplated hereby.

 

Except
as herein expressly amended, modified and/or supplemented, all terms, covenants and provisions of the are and shall remain in full force
and effect and all references therein to the Side Letters shall henceforth refer to the Side Letters as amended by this Amendment. This
Amendment shall be deemed incorporated into, and a part of, the Side Letters.

     

     

    

Target
Capital 3

March
30, 2022

Page
4

 

This
Amendment and any and all matters arising directly or indirectly herefrom, or relating directly or indirectly hereto, shall be
governed by, construed and enforced in accordance with the internal laws of the State of Arizona applicable to agreements made and
to be performed entirely in such state, without giving effect to the conflict or choice of law principles thereof. To the extent not
prohibited by applicable law that cannot be waived, each party hereto waives, and covenants that such party will not assert (whether
as plaintiff, defendant or otherwise), any right to trial by jury in any forum in respect of any issue, claim or proceeding arising
out of this Amendment or the subject matter hereof or in any way connected with the dealings of any party hereto in connection with
any of the above, in each case whether now existing or hereafter arising and whether in contract, tort or otherwise. Each party
agrees to the jurisdiction of the courts located in the Borough of Manhattan, New York City, New York.

 

This
Amendment may be executed in two or more counterparts, including by facsimile signature or .pdf copy, each of which shall be deemed an
original and all of which together shall constitute one instrument.

 

This
Amendment constitutes the full and entire understanding and agreement between the parties with respect to the subject matter hereof,
and is meant to be applied to the Extension Agreement and the Consulting Agreement Amendment as set forth herein. This Amendment can
only be amended with the written consent of the Investor and the Company.

 

This
Amendment is limited by its terms and does not and shall not serve to amend or waive any provision of the Note Purchase Agreement, Note,
Warrant or Registration Rights Agreement except as expressly provided for herein.

 

This
Amendment is solely for the benefit of the parties hereto and for Alchemy as set forth herein as a third party beneficiary, and is not
assignable by any party without the prior written consent of the other party.

 

[SIGNATURES
APPEAR ON THE NEXT PAGE.]

     

     

    

Target
Capital 3

March
30, 2022

Page
5

 

	 	Very truly yours,
	 	 	 
	 	ADAMAS ONE CORP.
	 	 	 
	 	By: 	/s/ John Grdina
	 	 	John Grdina
	 	 	Chief Executive Officer
	 	 	Dated: March 30, 2022

 

Agreed
and accepted:

 

TARGET
CAPITAL 3 LLC

 

	By: 	/s/ Dmitriy Shapiro

 

Name:
Dmitriy Shapiro

 

Title:
Founder

 

Dated:
March 30, 2022

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]